Skip to main content

Trends in Healthcare Utilization During the COVID-19 Pandemic: A Follow Up Propensity Score Matched and Stratified Analysis

Basic Details
Date Posted
Status
Complete
Medical Product
ACE inhibitors
beta blockers
Health Outcome(s)
angioedema
Description

This analysis assessed the risk of angioedema following initiation of treatment with angiotensin converting enzyme (ACE) inhibitors or beta blockers using data from 2018 to 2022 in the Sentinel Distributed Database. This is a follow up to a previous analysis that estimates changes in healthcare utilization in three periods throughout the pandemic using the Merative™ MarketScan® Research Databases.

The study period includes data from January 1, 2018 through June 30, 2022. We distributed this request to five Sentinel Data Partners on October 24, 2023.

The analytic package associated with this analysis can be found externally in Sentinel's Git Repository located here. The Git Repository serves as Sentinel's version control tracking system for analytic packages and technical documentation.

Deliverables (2)
Sentinel Modular Program Report: Trends in Healthcare Utilization During the COVID-19 Pandemic: A Follow Up Propensity Score Matched and Stratified Analysis Sentinel Analytic Package: Trends in Healthcare Utilization During the COVID-19 Pandemic: A Follow Up Propensity Score Matched and Stratified Analysis
Additional Details
FDA Center
CDER
Time Period
January 1, 2018 - June 30, 2022
Analysis Type
Retrospective Inferential
Population / Cohort
Individuals 18 years of age and older
Data Sources
Sentinel Distributed Database (SDD)
Related Links
Sentinel Drug Study: Trends in Healthcare Utilization During the COVID-19 Pandemic